Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on May 19th, 2023%
A new challenge competition seeks biomarkers, models, and clinical tests of the factors behind responses to stress conditions in human aging that can stave off frailty or death. . . . → Read More: $60M Challenge Seeks Biomarkers, Models to Counter Aging Stress
By Alan, on May 18th, 2023%
A company creating brain-computer interface devices to help people with disabling communications impairments is raising $33 million in its first venture round. . . . → Read More: Brain-Computer Device Company Gains $33M in Early Funds
By Alan, on May 17th, 2023%
A clinical trial shows a peel-and-stick patch device is as effective as a standard syringe injection in delivering a vaccine that protects against measles and rubella. . . . → Read More: Measles-Rubella Patch Vaccine Shown Effective as Injection
By Alan, on May 16th, 2023%
A developer of ultrasound bubbles to assist gene therapies is studying use of the technology with Janssen Pharmaceuticals for delivering DNA and RNA treatments. . . . → Read More: Biotech, Janssen Partner on Ultrasound for Gene Therapy
By Alan, on May 15th, 2023%
A company offering a search engine to help diagnose rare diseases is integrating generative models from Open AI into its artificial intelligence algorithms. . . . → Read More: Rare Disease Search Adds Large Language Model A.I.
By Alan, on May 9th, 2023%
A study of people with type 2 diabetes shows those using a digital diabetes management system made fewer hospital visits than non-users over a 12-month period. . . . → Read More: Digital Diabetes System Shown to Cut Health Care Use
By Alan, on May 2nd, 2023%
A genomic analysis of urine samples is shown to predict the most common form of bladder cancer years before symptoms appear. . . . → Read More: DNA Test Detects Early Bladder Cancer in Urine
By Alan, on April 21st, 2023%
A maker of diagnostics for infectious diseases is receiving a $53.7 million contract to develop and validate reliable home molecular tests for Covid-19 and flu infections. . . . → Read More: Biotech Gains $53.7M Infectious Disease Test Award
By Alan, on April 18th, 2023%
A venture capital company supporting developers of digital technologies in health care says it raised $460 million to invest in early-stage digital health businesses. . . . → Read More: New Funds to Invest in Digital Health Start-Ups
By Alan, on April 11th, 2023%
A start-up company with a process for harvesting large quantities of cells that infiltrate and kill solid tumors is raising $10 million in seed venture funds. . . . → Read More: Cancer Cell Therapy Biotech Launches, Raises $10M
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|